Deficiency of nuclear receptor interaction protein leads to cardiomyopathy by disrupting sarcomere structure and mitochondrial respiration

J Mol Cell Cardiol. 2019 Dec:137:9-24. doi: 10.1016/j.yjmcc.2019.09.009. Epub 2019 Oct 17.

Abstract

Background: Cardiomyopathy is a common and lethal complication in patients with limb-girdle muscular dystrophy (LGMD), one of the most prevalent forms of muscular dystrophy. The pathogenesis underlying LGMD-related cardiomyopathy remains unclear. NRIP (gene name DCAF6), a Ca2+-dependent calmodulin binding protein, was reduced in dystrophic muscles from LGMD patients. Mice lacking NRIP exhibit a myopathic phenotype resembling that in LGMD patients, making NRIP deficiency a potential culprit leading to cardiomyopathy. This study aimed to determine if NRIP deficiency leads to cardiomyopathy and to explore the underlying molecular mechanisms.

Methods and results: NRIP expression was reduced in both human and mouse failing hearts. Muscle-specific NRIP knockout (MCK-Cre::Dcaf6flox/flox) mouse heart and isolated cardiomyocytes exhibited markedly reduced contractility. Transmission electron microscopy revealed abnormal sarcomere structures and mitochondrial morphology in MCK-Cre::Dcaf6flox/flox hearts. Protein co-immunoprecipitation and confocal imaging revealed that NRIP interacts with α-actinin 2 (ACTN2) at the Z-disc. We found that NRIP facilitated ACTN2-mediated F-actin bundling, and that NRIP deficiency resulted in reduced binding between Z-disc proteins ACTN2 and Cap-Z. In addition, NRIP-deficiency led to increased mitochondrial ROS and impaired mitochondrial respiration/ATP production owing to elevated cellular NADH/NAD+ ratios. Treatment with mitochondria-directed antioxidant mitoTEMPO or NAD+ precursor nicotinic acid restored mitochondrial function and cardiac contractility in MCK-Cre::Dcaf6flox/flox mice.

Conclusions: NRIP is essential to maintain sarcomere structure and mitochondrial/contractile function in cardiomyocytes. Our results revealed a novel role for NRIP deficiency in the pathogenesis of LGMD and heart failure. Targeting NRIP, therefore, could be a powerful new approach to treat myocardial dysfunction in LGMD and heart failure patients.

Keywords: (3–5): NRIP; Animal Models of Human Disease; Basic Science Research; Cardiomyopathy; Contractile function; LGMD; Mitochondria; Oxidant Stress; Z-disc.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actinin / metabolism
  • Actins / metabolism
  • Adenosine Triphosphate / metabolism
  • Animals
  • Calcium / metabolism
  • Cardiomyopathies / metabolism*
  • Cardiomyopathies / physiopathology
  • Cell Respiration / drug effects
  • Down-Regulation / drug effects
  • Down-Regulation / genetics
  • Heart Failure / genetics
  • Homeostasis / drug effects
  • Humans
  • Male
  • Mice
  • Mitochondria, Heart / drug effects
  • Mitochondria, Heart / metabolism*
  • Mitochondria, Heart / ultrastructure
  • Models, Biological
  • Myocardial Contraction / drug effects
  • Myocardium / metabolism
  • Myocardium / pathology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • NAD / metabolism
  • Niacin / pharmacology
  • Nuclear Receptor Interacting Protein 1 / chemistry
  • Nuclear Receptor Interacting Protein 1 / metabolism*
  • Phenotype
  • Protein Binding / drug effects
  • Protein Domains
  • Reactive Oxygen Species / metabolism
  • Sarcomeres / drug effects
  • Sarcomeres / metabolism*
  • Sarcomeres / ultrastructure

Substances

  • Actins
  • Nuclear Receptor Interacting Protein 1
  • Reactive Oxygen Species
  • NAD
  • Actinin
  • Niacin
  • Adenosine Triphosphate
  • Calcium